全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Low CD4/CD8 Ratio in Bronchus-Associated Lymphoid Tissue Is Associated with Lung Allograft Rejection

DOI: 10.1155/2012/928081

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background. Bronchus-associated lymphoid tissue (BALT) has been associated with lung allograft rejection in rat transplant models. In human transplant recipients, BALT has not been linked to clinically significant rejection. We hypothesize that the immunohistochemical composition of BALT varies with the presence of acute lung allograft rejection. Methods. We retrospectively examined 40 human lung allograft recipients transplanted from 3/1/1999 to 6/1/2008. Patients were grouped by frequency and severity of acute rejection based on International Society of Heart Lung Transplant (ISHLT) criteria. Transbronchial biopsies were reviewed for BALT by a blinded pathologist. BALT if present was immunohistochemically stained to determine T-and B-cell subpopulations. Results. BALT presence was associated with an increased frequency of acute rejection episodes in the first year after transplantation. Patients with a lower CD4/CD8 ratio had an increased rejection rate; however, BALT size or densities of T-cell and B-cell subpopulations did not correlate with rejection rate. Conclusion. The presence of BALT is associated with an increased frequency of rejection one year after transplant. The lower the CD4/CD8 ratio, the more acute rejection episodes occur in the first year after transplantation. The immunohistochemical composition of BALT may predict patients prone to frequent episodes of acute cellular rejection. 1. Introduction Bronchus-associated lymphoid tissue (BALT) presence has been described in many animal species and in normal human lung tissue. BALT consists of follicular lymphoid aggregates within the mucosa of the bronchial tree [1]. BALT plays a role in local host defense similar to gut associated lymphoid tissue and tonsils. In addition, it is involved in antigen distribution and processing between the lung tissue and the mediastinal lymph nodes. In humans with inflammatory disease such as chronic obstructive pulmonary disease (COPD) and rheumatologic lung diseases the presence and number of BALT increases as the severity of disease worsens [2, 3]. Specifically there are an increased number of lymphoid follicles as the degree of airflow obstruction worsens in COPD [2]. In diseases such as rheumatoid lung, the presence of well-organized BALT is associated with the local expression of cytokines and enzymes that play a role in the pathobiology of autoimmune lung diseases [3]. BALT is often seen on transbronchial biopsy (TBBx) specimens in lung transplantation; however, the significance of its presence is not well understood. In rat transplantation models,

References

[1]  J. Bienenstock, “Bronchus associated lymphoid tissue and the source of immunoglobulin containing cells in the mucosa,” Environmental Health Perspectives, vol. 35, pp. 39–42, 1980.
[2]  J. C. Hogg, F. Chu, S. Utokaparch et al., “The nature of small-airway obstruction in chronic obstructive pulmonary disease,” New England Journal of Medicine, vol. 350, no. 26, pp. 2645–2653, 2004.
[3]  J. Rangel-Moreno, L. Hartson, C. Navarro, M. Gaxiola, M. Selman, and T. D. Randall, “Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis,” Journal of Clinical Investigation, vol. 116, no. 12, pp. 3183–3194, 2006.
[4]  J. Prop, P. Nieuwenhuis, and C. R. H. Wildevuur, “Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes,” Transplantation, vol. 40, no. 1, pp. 25–30, 1985.
[5]  T. Hasegawa, A. Iacono, and S. A. Yousem, “The significance of bronchus-associated lymphoid tissue in human lung transplantation: Is there an association with acute and chronic rejection?” Transplantation, vol. 67, no. 3, pp. 381–385, 1999.
[6]  J. De Blic, M. Peuchmaur, F. Carnot et al., “Rejection in lung transplantation—an immunohistochemical study of transbronchial biopsies,” Transplantation, vol. 54, no. 4, pp. 639–644, 1992.
[7]  S. A. Yousem, G. J. Berry, P. T. Cagle et al., “Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group,” Journal of Heart and Lung Transplantation, vol. 15, no. 1 I, pp. 1–15, 1996.
[8]  S. A. Yousem, T. Martin, I. L. Paradis, R. Keenan, and B. P. Griffith, “Can immunohistological analysis of transbronchial biopsy specimens predict responder status in early acute rejection of lung allografts?” Human Pathology, vol. 25, no. 5, pp. 525–529, 1994.
[9]  S. G. Kelsen, M. O. Aksoy, M. Georgy et al., “Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 9, pp. 799–805, 2009.
[10]  A. L. Gregson, A. Hoji, R. Saggar et al., “Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection,” Transplantation, vol. 85, no. 7, pp. 1056–1059, 2008.
[11]  F. Meloni, P. Vitulo, A. M. Bianco et al., “Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome,” Transplantation, vol. 77, no. 5, pp. 762–766, 2004.
[12]  J. R. Kocks, A. C. M. Davalos-Misslitz, G. Hintzen, L. Ohl, and R. F?rster, “Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue,” Journal of Experimental Medicine, vol. 204, no. 4, pp. 723–734, 2007.
[13]  C. M. Burton, M. Iversen, T. Scheike, J. Carlsen, and C. B. Andersen, “Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 27, no. 10, pp. 1128–1134, 2008.
[14]  M. M. Chakinala, J. Ritter, B. F. Gage et al., “Reliability for grading acute rejection and airway inflammation after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 24, no. 6, pp. 652–657, 2005.
[15]  S. Bhorade, V. Valentine, V. Ahya, M. Baz, and S. Arcasoy, “Interobserver variability of acute cellular lung rejection: a review of 310 surveillance biopsies from the AIRSAC trial,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 1, Meeting Abstracts, A2542, 2009.
[16]  S. Stewart, M. C. Fishbein, G. I. Snell et al., “Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection,” Journal of Heart and Lung Transplantation, vol. 26, no. 12, pp. 1229–1242, 2007.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133